These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

129 related items for PubMed ID: 6336776

  • 1. Evaluation of electrical aggregometry: comparison with optical aggregometry, secretion of ATP, and accumulation of radiolabeled platelets.
    Ingerman-Wojenski C, Smith JB, Silver MJ.
    J Lab Clin Med; 1983 Jan; 101(1):44-52. PubMed ID: 6336776
    [Abstract] [Full Text] [Related]

  • 2. Comparison of platelet aggregation using light transmission and multiple electrode aggregometry in Glanzmann thrombasthenia.
    Awidi A, Maqablah A, Dweik M, Bsoul N, Abu-Khader A.
    Platelets; 2009 Aug; 20(5):297-301. PubMed ID: 19548178
    [Abstract] [Full Text] [Related]

  • 3. Clopidogrel anti-platelet effect: an evaluation by optical aggregometry, impedance aggregometry, and the platelet function analyzer (PFA-100).
    Dyszkiewicz-Korpanty A, Olteanu H, Frenkel EP, Sarode R.
    Platelets; 2007 Nov; 18(7):491-6. PubMed ID: 17852774
    [Abstract] [Full Text] [Related]

  • 4. The effect of streptozocin-induced diabetes on platelet aggregation as determined by impedance aggregometry and platelet secretion: a possible role for nitric oxide.
    Judge S, Mammen E, Dunbar JC.
    J Assoc Acad Minor Phys; 1995 Nov; 6(3):100-4. PubMed ID: 7663098
    [Abstract] [Full Text] [Related]

  • 5. An assessment of cardiopulmonary bypass-induced changes in platelet function using whole blood and classical light transmission aggregometry: the results of a pilot study.
    Velik-Salchner C, Maier S, Innerhofer P, Kolbitsch C, Streif W, Mittermayr M, Praxmarer M, Fries D.
    Anesth Analg; 2009 Jun; 108(6):1747-54. PubMed ID: 19448196
    [Abstract] [Full Text] [Related]

  • 6. Assessment of ADP-induced platelet aggregation with light transmission aggregometry and multiple electrode platelet aggregometry before and after clopidogrel treatment.
    Sibbing D, Braun S, Jawansky S, Vogt W, Mehilli J, Schömig A, Kastrati A, von Beckerath N.
    Thromb Haemost; 2008 Jan; 99(1):121-6. PubMed ID: 18217143
    [Abstract] [Full Text] [Related]

  • 7. Spontaneous platelet aggregation in a hereditary giant platelet syndrome (MPS).
    Milton JG, Frojmovic MM, Tang SS, White JG.
    Am J Pathol; 1984 Feb; 114(2):336-45. PubMed ID: 6696046
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Detection of platelet aggregates with a particle counting method using light scattering.
    Ozaki Y, Satoh K, Yatomi Y, Yamamoto T, Shirasawa Y, Kume S.
    Anal Biochem; 1994 May 01; 218(2):284-94. PubMed ID: 8074282
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. The in-vitro effect of tirofiban, glycoprotein IIb/IIIa antagonist, on various responses of porcine blood platelets.
    Ciborowski M, Tomasiak M, Rusak T, Winnicka K, Dobrzycki S.
    Blood Coagul Fibrinolysis; 2008 Sep 01; 19(6):557-67. PubMed ID: 18685439
    [Abstract] [Full Text] [Related]

  • 12. Platelet function assays.
    Rand ML, Leung R, Packham MA.
    Transfus Apher Sci; 2003 Jun 01; 28(3):307-17. PubMed ID: 12725958
    [Abstract] [Full Text] [Related]

  • 13. PGI2 and PGE1 induce morphological alterations in human platelets similar to those of the initial phase of activation.
    Zilla P, Groscurth P, Varga G, Fischlein T, Fasol R.
    Exp Hematol; 1987 Aug 01; 15(7):741-9. PubMed ID: 3301381
    [Abstract] [Full Text] [Related]

  • 14. Deficiency of (33P)2MeS-ADP binding sites on platelets with secretion defect, normal granule stores and normal thromboxane A2 production. Evidence that ADP potentiates platelet secretion independently of the formation of large platelet aggregates and thromboxane A2 production.
    Cattaneo M, Lombardi R, Zighetti ML, Gachet C, Ohlmann P, Cazenave JP, Mannucci PM.
    Thromb Haemost; 1997 May 01; 77(5):986-90. PubMed ID: 9184415
    [Abstract] [Full Text] [Related]

  • 15. Inhibition of platelet aggregation by 1-methyl-4-phenyl pyridinium ion (MPP+) through ATP depletion: Evidence for the reduced platelet activities in Parkinson's disease.
    Lim KM, Kim HH, Bae ON, Noh JY, Kim KY, Kim SH, Chung SM, Shin S, Kim HY, Chung JH.
    Platelets; 2009 May 01; 20(3):163-70. PubMed ID: 19437333
    [Abstract] [Full Text] [Related]

  • 16. Disaggregatory effects of prostaglandin E1, amrinone and milrinone on platelet aggregation in human whole blood.
    Kikura M, Kazama T, Ikeda T, Sato S.
    Platelets; 2000 Dec 01; 11(8):446-58. PubMed ID: 11177444
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. ADP-mimicking platelet aggregation caused by rugosin E, an ellagitannin isolated from Rosa rugosa Thunb.
    Teng CM, Kang YF, Chang YL, Ko FN, Yang SC, Hsu FL.
    Thromb Haemost; 1997 Mar 01; 77(3):555-61. PubMed ID: 9066010
    [Abstract] [Full Text] [Related]

  • 19. Evaluation of platelet function, a method comparison.
    Nylander S, Johansson K, Van Giezen JJ, Lindahl TL.
    Platelets; 2006 Feb 01; 17(1):49-55. PubMed ID: 16308187
    [Abstract] [Full Text] [Related]

  • 20. Mechanisms underlying increased platelet reactivity in patients with peripheral arterial disease. Preliminary results.
    Reininger CB, Boeger CA, Steckmeier B, Spannagl M, Scweiberer L.
    Int Angiol; 1999 Jun 01; 18(2):163-70. PubMed ID: 10424375
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.